Abstract

Alternative splicing in mammalian cells has been suggested to be largely controlled by combinatorial binding of basal splicing factors to pre-mRNA templates. This model predicts that distinct sets of pre-mRNA splicing factors are associated with alternatively spliced transcripts. However, no experimental evidence for differential recruitment of splicing factors to transcripts with distinct splicing fates is available. Here we have used quantitative single-cell imaging to test this key prediction in vivo. We show that distinct combinations of splicing factors are recruited to sites of alternatively spliced transcripts in intact cells. While a subset of serine/arginine protein splicing factors, including SF2/ASF, SC35, and SRp20, is efficiently recruited to the tau gene when exon 10 is included, these factors are less frequently associated with tau transcription sites when exon 10 is excluded. In contrast, the frequency of recruitment of several other splicing factors is independent of splicing outcome. Mutation analysis of SF2/ASF shows that both protein–protein as well as protein–RNA interactions are required for differential recruitment. The differential behavior of the various splicing factors provides the basis for combinatorial occupancy at pre-mRNAs. These observations represent the first in vivo evidence for differential association of pre-mRNA splicing factors with alternatively spliced transcripts. They confirm a key prediction of a stochastic model of alternative splicing, in which distinct combinatorial sets of generic pre-mRNA splicing factors contribute to splicing outcome.

Highlights

  • Pre-mRNA splicing is one of the key steps in the maturation of newly synthesized transcripts

  • Non-coding intron sequences are removed and the coding exon sequences are joined in a multi-step reaction, carried out by the spliceosome, a large protein complex consisting of small ribonucleoprotein particles, and associated non-snRNP proteins [1,2]

  • As a model system we used the tau gene, which encodes a microtubule binding protein and whose aberrant alternative splicing is the cause of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), a parkinsonism-like neurological disorder [29]

Read more

Summary

Introduction

Pre-mRNA splicing is one of the key steps in the maturation of newly synthesized transcripts. Non-coding intron sequences are removed and the coding exon sequences are joined in a multi-step reaction, carried out by the spliceosome, a large protein complex consisting of small ribonucleoprotein particles (snRNP), and associated non-snRNP proteins [1,2]. During the alternative splicing reaction multiple mRNA species are generated by combinatorial inclusion or exclusion of exons [5,6,7,8,9]. Defects in alternative splicing and generation of aberrant ratios of multiple mRNA isoforms from a single gene are recognized as major contributors to human disease [11,12,13]. Alternative splicing defects have been identified as the cause of numerous diseases including bthalassemia, cystic fibrosis, and premature aging [11]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call